Good morning, everyone, and how are you today? A sunny morning is unfolding over the Pharmalot corporate campus, where we are ahead of schedule in depositing the short people at the local schoolhouses. To celebrate, yes, we are downing a much-needed cup of stimulation. And this is a needed jolt, because there is much to do today as we brace for meetings, deadlines and piles of documents. We know you relate. So here are a few tidibits to help you along. Have a great day...
AstraZeneca And Targacept Depression Drugs Fails Study Goal (Reuters)
BioCryst Gout Drug Helps Patients In Trial (Bloomberg News)
NABI Reviews Options After Anti-Smoking Vaccine Fails Trial (Bloomberg News)
Allergan Gets $17M Grant To Build NJ Plant And Add 400 Jobs (Wall Street Journal)
Amgen Plans To Buyback $5 Billion In Stock (Bloomberg News)
Teva Must Pay Pfizer Court Fees In Viagra Patent Fight (Courthouse News)
Amgen Vectibix Trial Halted Over Inferior Outcomes (Dow Jones)
FDA Approves Wider Use Of Erbitux (Pharma Times)
EDITOR'S NOTE: Please check this post for updates throughout the morning